Thermo Fisher invests $25M in sterile injectables facility in Monza, Italy

Thermo Fisher's Pharma Services announced a $25 million investment in its Monza, Italy site to establish sterile injectables development capabilities. The 2,300 m² facility is expected to be fully operational in the second half of 2019.

“Thermo Fisher’s Pharma Services announced the $25 million investment in its Monza, Italy site to establish state-of-the-art development capabilities.”bioprocessonline.com

• 1 source
• bioprocessonline.comThermo Fisher Continues To Expand Sterile Injectables Development Capabilities In Monza ItalyJun 26, 2018

Summarized from public sources; check the original articles before acting on it.